How do St. Joseph (OTC aspirin) and Bayer low-dose aspirin sales compare?
The information provided doesn’t include market-share or sales figures for “St. Joseph” vs Bayer’s low-dose aspirin products, so a direct comparison can’t be made from the supplied material.
Is “St. Joseph” the same as St. Joseph Aspirin (private label) or another brand?
Many “St. Joseph” aspirin listings in the U.S. are store/house brands or pharmacy-distributed products, and their sales are often reported differently than national branded products (like Bayer’s). That can make “market share” comparisons inconsistent unless both brands are defined the same way (same dose, same formulation, and same reporting channel: retail, drugstores, total U.S., etc.).
What data sources are typically used for aspirin brand market share/sales?
Brand and sales comparisons for OTC products usually come from paywalled retail scanner panels or industry trackers (for example: Circana/IRI, NielsenIQ) and/or company financial disclosures. If you share:
- the exact product name(s) (e.g., “St. Joseph Low Dose Aspirin 81 mg”),
- geography (U.S. only?),
- time period (latest quarter/year?),
- channel (mass, drugstores, online, total retail?),
I can narrow the answer to the right kind of market-share metric.
If you want Bayer specifically, which product matters?
Bayer’s low-dose aspirin is commonly referenced as 81 mg (often marketed as “Low Dose Aspirin”). Market-share results can differ between:
- Bayer brand vs “generic 81 mg” categories,
- pharmacy channels vs total U.S. retail.
Quick next step
Send the exact St. Joseph aspirin product name(s) you mean (and whether you want U.S. retail only, or total including online), and I’ll map the comparison to the most likely available market-share/sales measures.
Sources
No sources were provided in the prompt to cite.